CNTA vs IVZ · $6.15B cap vs rev $3.57B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
CNTA currently screens at market cap $6.15B. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the CNTA and IVZ stock pages for the full models.
Not investment advice.